Extracorporeal membrane oxygenation in cardiopulmonary disease in adults, Journal of the American College of Cardiology, vol.63, pp.2769-78, 2014. ,
,
The ICM research agenda on extracorporeal life support, Intensive care medicine, vol.43, pp.1306-1318, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01677426
Prognostic Impact of Persistent Thrombocytopenia During Extracorporeal Membrane Oxygenation: A Retrospective Analysis of Prospectively Collected Data From a Cohort of Patients With Left Ventricular Dysfunction After Cardiac Surgery, Critical care medicine, vol.44, pp.1208-1218, 2016. ,
The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology, Critical care, vol.20, p.387, 2016. ,
,
Extracorporeal membrane oxygenation-hemostatic complications, Transfusion medicine reviews, vol.29, pp.90-101, 2015. ,
,
Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery, Circulation, vol.95, pp.1242-1248, 1997. ,
,
, Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia, Circulation, vol.99, pp.2530-2536, 1999.
,
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive, Journal of thrombosis and haemostasis : JTH, vol.8, pp.30-36, 2010. ,
What's new about heparin-induced thrombocytopenia type II, Intensive care medicine, vol.41, pp.1824-1831, 2015. ,
,
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation, Journal of critical care, vol.30, pp.1190-1194, 2015. ,
Platelet Count Trends and Prevalence of Heparin-Induced Thrombocytopenia in a Cohort of Extracorporeal Membrane Oxygenator Patients, Critical care medicine, vol.44, pp.1031-1037, 2016. ,
How I treat heparin-induced thrombocytopenia, Blood, vol.119, pp.2209-2227, 2012. ,
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings, Journal of thrombosis and haemostasis : JTH, vol.4, pp.759-65, 2006. ,
Consequences of treating false positive heparin-induced thrombocytopenia, Journal of thrombosis and thrombolysis, vol.40, pp.512-516, 2015. ,
,
Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study, Critical care, vol.17, p.73, 2013. ,
,
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Critical care and resuscitation : journal of the Australasian Academy of, Critical Care Medicine, vol.15, pp.172-180, 2013. ,
,
Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score, European heart journal, vol.36, pp.2246-56, 2015. ,
Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the ,
, Extracorporeal Life Support Organization (ELSO) registry, Critical care
The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology, Critical Care, vol.20, p.387, 2016. ,
,
Interaction of platelet factor 4 with human platelets, Biochimica et Biophysica Acta, vol.839, pp.161-173, 1985. ,
, Recherche d'anticorps potentiellement responsables d'une thrombopénie induite par l'héparine, HAS, 2005.
Heparin-induced thrombocytopenia: pathogenesis and management, British Journal of Haematology, vol.121, pp.535-555, 2003. ,
Heparin-induced thrombocytopenia: principles for early recognition and management, Cleveland Clinic Journal of Medicine, vol.72, pp.31-36, 2005. ,
Heparin-associated thrombocytopenia: the antibody is not heparin specific, Thrombosis and Haemostasis, vol.67, pp.545-549, 1992. ,
,
Antibodies to macromolecular platelet factor 4heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases, Thrombosis and Haemostasis, vol.73, pp.21-28, 1995. ,
, Fareed J, 2004.
, immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis, Molecular and Cellular Biochemistry, vol.258, pp.163-170
, , 2005.
, Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?, The Journal of Laboratory and clinical Medicine, vol.146, pp.341-346
, , 2008.
, Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings, Thrombosis Research, vol.122, pp.211-220
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia, Blood, vol.97, pp.3300-3302, 2001. ,
In vitro effects of platelet factor 4 on normal human neutrophil functions, Journal of Leukocyte Biology, vol.39, pp.423-434, 1986. ,
Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach, Seminars in Thrombosis and Hemostasis, vol.40, pp.106-114, 2014. ,
Treatment and prevention of heparin, 2012. ,
, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Antithrombotic Therapy and Prevention of Thrombosis, vol.141, pp.495-530
, , 2006.
, Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings, Journal of Thrombosis and Haemostasis : JTH, vol.4, pp.759-765
Impact of the patient population on the risk for heparin-induced thrombocytopenia, Blood, vol.96, pp.1703-1708, 2000. ,
,
The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia, Blood, vol.115, pp.1797-1803, 2010. ,
Heparin-induced thrombocytopenia and cardiac surgery, The Annals of Thoracic Surgery, vol.76, pp.638-648, 2003. ,
Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia, European Journal of Haematology, vol.76, pp.420-426, 2006. ,
A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex, Seminars in Thrombosis and Hemostasis, vol.30, pp.359-368, 2004. ,
Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia, Thrombosis and Haemostasis, vol.116, pp.823-834, 2016. ,
New approaches to the diagnosis of heparin-induced thrombocytopenia, Chest, vol.127, pp.35-45, 2005. ,
,
Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors, Journal of Critical Care, vol.20, pp.348-353, 2005. ,
, , 2013.
, Thrombocytopenia in the intensive care unit-diagnostic approach and management, Seminars in Hematology, vol.50, pp.239-250
,
,
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes, Chest, vol.144, pp.1207-1215, 2013. ,
,
Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study, Intensive Care Medicine, vol.42, pp.844-852, 2016. ,
,
Prognostic Impact of Persistent Thrombocytopenia During Extracorporeal Membrane Oxygenation: A Retrospective Analysis of Prospectively Collected Data From a Cohort of Patients With Left Ventricular Dysfunction After Cardiac Surgery, Critical Care Medicine, vol.44, pp.1208-1218, 2016. ,
Argatroban therapy in heparininduced thrombocytopenia with hepatic dysfunction, Chest, vol.129, pp.1167-1175, 2006. ,
Argatroban: update, American Heart Journal, vol.151, pp.1131-1138, 2006. ,
, , 2010.
, Heparin-induced thrombocytopenia type II after cardiac surgery: predictors and outcome, The Thoracic and Cardiovascular Surgeon, vol.58, pp.463-467
,
Heparininduced thrombocytopenia in patients receiving mechanical circulatory support, The Journal of Thoracic and Cardiovascular Surgery, vol.131, pp.1373-1381, 1374. ,
,
, IgG classification of anti, 2007.
, PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support, Journal of Thrombosis and Haemostasis : JTH, vol.5, pp.235-241
,
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation, Journal of Critical Care, vol.30, pp.1190-1194, 2015. ,
, , 2016.
, Platelet Count Trends and Prevalence of Heparin-Induced Thrombocytopenia in a Cohort of Extracorporeal Membrane Oxygenator Patients, Critical Care Medicine, vol.44, pp.1031-1037
,
Predicting survival after ECMO for refractory cardiogenic shock: the survival after venoarterial-ECMO (SAVE)-score, European Heart Journal, vol.36, pp.2246-2256, 2015. ,
Consequences of treating false positive heparin-induced thrombocytopenia, Journal of Thrombosis and Thrombolysis, vol.40, pp.512-514, 2015. ,
,
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive, Journal of Thrombosis and Haemostasis : JTH, vol.8, pp.30-36, 2010. ,
Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia, Circulation, vol.99, pp.2530-2536, 1999. ,
Proton pump induced thrombocytopenia: A case report and review of literature, Platelets, vol.26, pp.598-601, 2015. ,
analysis of 408 patients, Thrombosis and Haemostasis, vol.94, pp.132-135, 2005. ,
,
Prevalence of heparinassociated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery, Circulation, vol.95, pp.1242-1246, 1997. ,
Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations, Journal of Thrombosis and Thrombolysis, vol.44, pp.76-87, 2017. ,